Krolevets, Mykhailo
Cate, Vincent ten
Prochaska, Jürgen H.
Schulz, Andreas
Rapp, Steffen
Tenzer, Stefan
Andrade-Navarro, Miguel A.
Horvath, Steve
Niehrs, Christof
Wild, Philipp S.
Funding for this research was provided by:
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
Article History
Received: 9 December 2022
Accepted: 19 March 2023
First Online: 30 March 2023
Declarations
:
: Not applicable.
: Consent for publication was obtained from all authors before submission.
: None of the authors report any conflicts of interest with respect to the content of this article. PSW reports outside the submitted work: consulting fees from Astra Zeneca, research grants from Bayer AG, research grants, consulting and lecturing fees from Bayer Health Care, lecturing fees from Bristol Myers Squibb, grants and consulting fees from Boehringer Ingelheim, grants, consulting and lecturing fees from Daiichi Sankyo Europe, consulting fees and non-financial support from Diasorin, non-financial support from I.E.M., grants and consulting fees from Novartis Pharma, lecturing fees from Pfizer Pharma, non-financial grants from Philips Medical Systems, and grants and consulting fees from Sanofi-Aventis. JHP has received outside the submitted work: honoraria for lectures from Bayer AG, Boehringer Ingelheim, Daiichi Sankyo GmbH, and Sanofi-Aventis GmbH as well as research grants from the Federal Ministry of Education and Research (BMBF 01EO1503) and the German Center for Cardiovascular Research (DZHK).